Algorae Pharmaceuticals Limited

OTCPK:LVCL.F Stock Report

Market Cap: US$13.3m

Algorae Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

David Hainsworth

Chief executive officer

AU$40.0k

Total compensation

CEO salary percentage100.0%
CEO tenure1.6yrs
CEO ownership1.2%
Management average tenureless than a year
Board average tenure1.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Hainsworth's remuneration changed compared to Algorae Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$2m

Sep 30 2023n/an/a

-AU$2m

Jun 30 2023AU$40kAU$40k

-AU$2m

Compensation vs Market: David's total compensation ($USD26.26K) is below average for companies of similar size in the US market ($USD674.46K).

Compensation vs Earnings: Insufficient data to compare David's compensation with company performance.


CEO

David Hainsworth (49 yo)

1.6yrs

Tenure

AU$40,000

Compensation

Mr. David Richard Hainsworth is an Associate Director with Alignment Capital, principally focused on the origination and execution of primarily Australian Stock Exchange based capital market transactions w...


Leadership Team

NamePositionTenureCompensationOwnership
David Hainsworth
CEO & Executive Chairmanno dataAU$40.00k1.19%
A$ 157.6k
Daya Uka
Chief Financial Officer5.2yrsAU$153.71kno data
Belinda Bartolo
Chief Operations Officer2.4yrsAU$182.95kno data
Carolyn Sue
Member of Medical Advisory Board & Chief Medical Officer of NTCELLless than a yearAU$50.00k0.067%
A$ 8.9k
James Mckenna
Chief Scientific Officerless than a yearno datano data
Leah Pieris
Company Secretaryless than a yearno datano data

0.9yrs

Average Tenure

Experienced Management: LVCL.F's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
David Hainsworth
CEO & Executive Chairman1.6yrsAU$40.00k1.19%
A$ 157.6k
Carolyn Sue
Member of Medical Advisory Board & Chief Medical Officer of NTCELLno dataAU$50.00k0.067%
A$ 8.9k
Bradley Latham
Non-Executive Directorless than a yearno data1.19%
A$ 157.6k
Bradley Dilkes
Non-executive Director1.6yrsAU$33.33k1.19%
A$ 157.6k

1.6yrs

Average Tenure

54.5yo

Average Age

Experienced Board: LVCL.F's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.